이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
시장 규제 · 1995. 11. 7.1 분 읽기
The Upjohn Company and Pharmacia Aktiebolag; Consent Agreement With Analysis to Aid Public Comment
로컬 자동 번역 · 원본 출처 언어
요약
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would require The Upjohn Company and Pharmacia Aktiebolag to divest Pharmacia's assets in ``9-AC,'' a topoisomerase I inhibitor drug for the treatment of colorectal cancer, to a Commission-approved buyer who will ensure that research and development will continue in competition with the merged company's product ``CPT-11,'' a topoisomerase I inhibitor drug developed by Upjohn.
원본 출처 언어: Federal Register — Federal Trade Commission원문 발표 열기 →